A comparable pattern in necrosis frequency was noted in the ZSHC cohort although the difference did not reach statistical significance (Supplementary Fig.
← all excerpts
Lactate-Driven IL8+ Tumor-Associated Macrophages Mediate Immunosuppression and Resistance to Immunotherapy in Clear-Cell Renal Cell Carcinoma.
2
—
—
The sentences
Consistent associations were observed across external cohorts: higher IL8 levels showed a nonsignificant trend toward worse prognosis in the nivolumab-treated arm of the CheckMate cohort but a significant association in the atezolizumab plus bevacizumab arm of the IMmotion150 cohort, whereas no association was observed with everolimus (CheckMate) or sunitinib (IMmotion150) treatment (Supplementary Figs.